Masimo, the Only Patient Monitoring Company Included, Was One of Seven Featured California Innovators IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) is...
MOBILE, Ala.--(BUSINESS WIRE)--$CPSI--American HealthTech (AHT), a wholly owned subsidiary of CPSI (NASDAQ: CPSI) and a leading provider of electronic health...
BRECKSVILLE, Ohio--(BUSINESS WIRE)--#activearchiving--MediQuant®, the leading innovator and provider of enterprise-active archiving and conversion solutions for hospitals and health systems, has...
David Wardlaw appointed as Chief Revenue Officer RALEIGH, NC / ACCESSWIRE / December 7, 2020 / MobileSmith Health (OTCQB:MOST), a leader...
Partnership extends reach of Rhinogram's frictionless approach to care to thousands of oral health providers across the U.S. CHATTANOOGA, TN...
Exclusive agreement for Vietnam includes the sale of at least 40 liver imaging systems ANN ARBOR, MI / ACCESSWIRE /...
JACKSON CENTER, PA / ACCESSWIRE / December 7, 2020 / Halberd Corporation (OTC PINK:HALB) announced the promising results of laboratory...
The Nasdaq Listing Council, on its own motion, will consider if the Company should have been granted a longer period...
STUART, FL / ACCESSWIRE / December 7, 2020 / Prescription Hope, one of the largest patient assistance program administrators in...
TORONTO, ON / ACCESSWIRE / December 7, 2020 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS) today announced StageZero's...
VANCOUVER, BC / ACCESSWIRE / December 7, 2020 / Chemesis International Inc. (CSE:CSI.U) (OTCQB:CADMF) (FRA:CWAA) (the "Company" or "Chemesis"), announces...
LANGLEY, BC / ACCESSWIRE / December 7, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) ("Adastra") a Health Canada Licensed cannabis processing...
TORONTO, ON / ACCESSWIRE / December 7, 2020 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
-Rapid onset and sustained clinical effect following first dose in all 9 patients in total stool output (TSO) volume -Clinically...
-- First Dedicated Clinical Trial of an Anti-CD47 Antibody in Multiple Myeloma ---- At ASH 2020, New Preclinical Data Presented...
JATENZO is the first and only FDA-approved oral testosterone replacement therapy of its kind Coverage effective December 1, 2020 on...
NEW YORK, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical...
Phase 3 trials’ topline data anticipated in the first quarter of 2021 and potential New Drug Application (NDA) submission anticipated...
-- Results from the multiple-ascending dose trial demonstrate proof-of-concept for SRP-5051 and support continued dose escalation -- -- At a...
Saint-Herblain (France), December 7, 2020 – Valneva SE (“Valneva” or “the Company”) announces that due to the current COVID-19 epidemic...